Given the persistent importance of JAK/STAT signaling pathway in tumorigenesis in various cancers, including colorectal cancer, it is possible that simultaneous targeting of other regulators involved in this complex pathway and the optimization of combination therapy regimens may hold potential to achieve improved outcomes. Here, SOAT1 is linked to colorectal cancer.